Cetera Investment Advisers
BSX icon

Cetera Investment Advisers’s Boston Scientific BSX Stock Holding History

Cetera Investment Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.7M Sell
462,281
-11,119
-2% -$604K 0.02% 768
2026
Q1 		$29.7M Buy
473,400
+23,257
+5% +$1.86M 0.03% 531
2025
Q4 		$42.9M Buy
450,143
+7,993
+2% +$784K 0.05% 396
2025
Q3 		$43.2M Buy
442,150
+94,005
+27% +$9.74M 0.05% 372
2025
Q2 		$37.4M Buy
348,145
+13,412
+4% +$1.36M 0.06% 316
2025
Q1 		$33.8M Buy
334,733
+15,572
+5% +$1.57M 0.07% 304
2024
Q4 		$28.5M Buy
319,161
+14,789
+5% +$1.3M 0.06% 331
2024
Q3 		$25.5M Buy
304,372
+8,388
+3% +$661K 0.06% 351
2024
Q2 		$22.8M Buy
295,984
+8,399
+3% +$615K 0.05% 364
2024
Q1 		$19.7M Buy
287,585
+218,573
+317% +$14.1M 0.05% 396
2023
Q4 		$3.99M Sell
69,012
-607
-0.9% -$32.4K 0.03% 517
2023
Q3 		$3.68M Buy
69,619
+2,303
+3% +$121K 0.03% 518
2023
Q2 		$3.64M Buy
67,316
+6,962
+12% +$364K 0.03% 524
2023
Q1 		$3.02M Buy
60,354
+16,628
+38% +$784K 0.03% 570
2022
Q4 		$2.02M Buy
43,726
+14,568
+50% +$631K 0.02% 709
2022
Q3 		$1.13M Sell
29,158
-1,019
-3% -$40.9K 0.02% 666
2022
Q2 		$1.13M Buy
30,177
+1,384
+5% +$56.3K 0.02% 748
2022
Q1 		$1.27M Buy
28,793
+5,581
+24% +$242K 0.02% 733
2021
Q4 		$986K Buy
23,212
+2,305
+11% +$96.9K 0.01% 808
2021
Q3 		$907K Buy
20,907
+1,403
+7% +$62.1K 0.01% 805
2021
Q2 		$834K Buy
19,504
+5,986
+44% +$252K 0.01% 847
2021
Q1 		$522K Sell
13,518
-5,111
-27% -$193K 0.01% 955
2020
Q4 		$670K Buy
+18,629
New +$671K 0.01% 836

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cetera Investment Advisers's BSX Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Boston Scientific (BSX) stake by 2.3% in Q2 2026, selling an estimated $604K and leaving 462,281 shares worth $19.7M. The position accounts for 0.02% of the portfolio, ranked #768.

Cetera Investment Advisers first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $43.2M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cetera Investment Advisers held 462,281 shares of Boston Scientific worth $19.7M as of Q2 2026.
  • Cetera Investment Advisers sold 11,119 Boston Scientific shares in Q2 2026, an estimated $604K.
  • Boston Scientific made up 0.02% of Cetera Investment Advisers's portfolio in Q2 2026, its #768 holding.
  • Cetera Investment Advisers first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
  • Cetera Investment Advisers's Boston Scientific position peaked at $43.2M in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.